Literature DB >> 18568298

Characterization of c-kit (CD117) expression in human normal pituitary cells and pituitary adenomas.

Stefano La Rosa1, Silvia Uccella, Linda Dainese, Silvia Marchet, Claudia Placidi, Davide Vigetti, Carlo Capella.   

Abstract

c-kit (CD117) is a tyrosine kinase receptor involved in the proliferation, differentiation, and secretory functions of various cells. In experimental animal models, c-kit has been detected in the pars intermedia of the normal pituitary gland and in alpha-melanocyte-stimulating-hormone-positive adenomas and it has been suggested that it plays a role in regulating adrenocorticotropic hormone (ACTH) secretion. To the best of our knowledge, the expression of c-kit in normal human pituitary cells and in pituitary adenomas has never been reported, so the possible biological role of this receptor in the control of pituitary hormone secretion remains unclear. The aim of this study was to evaluate the immunohistochemical expression of c-kit in normal human pituitary glands and in a series of 62 well-characterized pituitary adenomas. In normal adenohypophyses, several cells, mainly located in the central mucoid wedge, showed a c-kit immunoreactivity (IR). Double label immunostaining procedures showed that the c-kit-IR cells corresponded to ACTH cells. Out of 62 adenomas, 15 (24%) were c-kit-IR, including 7/16 (44%) ACTH cell, 3/7 (42%) null cell, 4/11 (36%) alpha-subunit cell, and 1/11 (10%) follicle-stimulating hormone-luteinizing hormone cell adenomas. By contrast, all ten prolactin cell and seven growth hormone cell adenomas were c-kit negative. These data suggest that, in normal conditions, c-kit may be involved in the pituitary-adrenal axis regulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18568298     DOI: 10.1007/s12022-008-9032-4

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  38 in total

1.  KIT receptor (CD117) expression in Merkel cell carcinoma.

Authors:  S Strong; K Shalders; R Carr; D R J Snead
Journal:  Br J Dermatol       Date:  2004-02       Impact factor: 9.302

2.  Immunohistochemical detection of fibroblast growth factor receptors in normal endocrine cells and related tumors of the digestive system.

Authors:  S La Rosa; S Uccella; S Erba; C Capella; F Sessa
Journal:  Appl Immunohistochem Mol Morphol       Date:  2001-12

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens.

Authors:  H Y Lan; W Mu; D J Nikolic-Paterson; R C Atkins
Journal:  J Histochem Cytochem       Date:  1995-01       Impact factor: 2.479

5.  The adult pituitary contains a cell population displaying stem/progenitor cell and early embryonic characteristics.

Authors:  Jianghai Chen; Nicole Hersmus; Vik Van Duppen; Pieter Caesens; Carl Denef; Hugo Vankelecom
Journal:  Endocrinology       Date:  2005-06-02       Impact factor: 4.736

6.  Signaling via Src family kinases is required for normal internalization of the receptor c-Kit.

Authors:  V C Broudy; N L Lin; W C Liles; S J Corey; B O'Laughlin; S Mou; D Linnekin
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

7.  Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features.

Authors:  Stefano La Rosa; Silvia Uccella; Giovanna Finzi; Luca Albarello; Fausto Sessa; Carlo Capella
Journal:  Hum Pathol       Date:  2003-01       Impact factor: 3.466

8.  Expression of c-kit receptor in normal and transformed human nonlymphoid tissues.

Authors:  P G Natali; M R Nicotra; I Sures; E Santoro; A Bigotti; A Ullrich
Journal:  Cancer Res       Date:  1992-11-15       Impact factor: 12.701

9.  Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.

Authors:  George D Demetri; Margaret von Mehren; Charles D Blanke; Annick D Van den Abbeele; Burton Eisenberg; Peter J Roberts; Michael C Heinrich; David A Tuveson; Samuel Singer; Milos Janicek; Jonathan A Fletcher; Stuart G Silverman; Sandra L Silberman; Renaud Capdeville; Beate Kiese; Bin Peng; Sasa Dimitrijevic; Brian J Druker; Christopher Corless; Christopher D M Fletcher; Heikki Joensuu
Journal:  N Engl J Med       Date:  2002-08-15       Impact factor: 91.245

10.  Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.

Authors:  Y Yarden; W J Kuang; T Yang-Feng; L Coussens; S Munemitsu; T J Dull; E Chen; J Schlessinger; U Francke; A Ullrich
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

View more
  8 in total

1.  KIT protein expression and mutational status of KIT gene in pituitary adenomas.

Authors:  Olivera Casar-Borota; Stine Lyngvi Fougner; Jens Bollerslev; Jahn Marthin Nesland
Journal:  Virchows Arch       Date:  2012-01-03       Impact factor: 4.064

Review 2.  ACTH-producing tumorlets and carcinoids of the lung: clinico-pathologic study of 63 cases and review of the literature.

Authors:  Stefano La Rosa; Marco Volante; Silvia Uccella; Roberta Maragliano; Ida Rapa; Nicola Rotolo; Frediano Inzani; Alessandra Siciliani; Pierluigi Granone; Guido Rindi; Lorenzo Dominioni; Carlo Capella; Mauro Papotti; Fausto Sessa; Andrea Imperatori
Journal:  Virchows Arch       Date:  2019-07-01       Impact factor: 4.064

3.  Expression of Wnt4 in human pituitary adenomas regulates activation of the beta-catenin-independent pathway.

Authors:  Takashi Miyakoshi; Mao Takei; Hanako Kajiya; Noboru Egashira; Susumu Takekoshi; Akira Teramoto; Robert Yoshiyuki Osamura
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

Review 4.  Gene expression in prolactinomas: a systematic review.

Authors:  Justin Seltzer; Thomas C Scotton; Keiko Kang; Gabriel Zada; John D Carmichael
Journal:  Pituitary       Date:  2016-02       Impact factor: 4.107

5.  Imatinib Inhibits GH Secretion From Somatotropinomas.

Authors:  Prakamya Gupta; Ashutosh Rai; Kanchan Kumar Mukherjee; Naresh Sachdeva; Bishan Das Radotra; Raj Pal Singh Punia; Rakesh Kumar Vashista; Debasish Hota; Anand Srinivasan; Sivashanmugam Dhandapani; Sunil Kumar Gupta; Anil Bhansali; Pinaki Dutta
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-27       Impact factor: 5.555

6.  Lateral one-third gland resection in Cushing patients with failed adenoma identification leads to low remission rates: long-term observations from a small, single-center cohort.

Authors:  Lukas Andereggen; Luigi Mariani; Jürgen Beck; Robert H Andres; Jan Gralla; Markus M Luedi; Joachim Weis; Emanuel Christ
Journal:  Acta Neurochir (Wien)       Date:  2021-04-03       Impact factor: 2.816

7.  The study of CD117 expression in glial tumors and its relationship with the tumor-type and grade.

Authors:  Parvin Mahzouni; Mohsen Jafari
Journal:  J Res Med Sci       Date:  2012-02       Impact factor: 1.852

8.  Combined KIT and FGFR2b signaling regulates epithelial progenitor expansion during organogenesis.

Authors:  Isabelle M A Lombaert; Shaun R Abrams; Li Li; Veraragavan P Eswarakumar; Aditya J Sethi; Robert L Witt; Matthew P Hoffman
Journal:  Stem Cell Reports       Date:  2013-12-12       Impact factor: 7.765

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.